Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication in Parkinson's Disease
NCT02108704Completed
- Sponsor
- Universiti Malaya
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of amoxicillin, clarithromycin and omeprazole in Helicobacter pylori infection (2 arms), sponsored by Universiti Malaya. Primary endpoint: Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III at 3 months. Started Dec 2013; status: completed.
02
Drugs
amoxicillinclarithromycinomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02108704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108704.